Latest Shareholder Value News

HUB24 Limited has announced a fully franked ordinary dividend of AUD 0.36 per share for the six months ending December 2025, signalling steady returns for shareholders.

Transurban Group posted robust half-year results for December 2025, with revenue climbing 8.1% and profit rebounding to $343 million. The company also declared a 34-cent interim distribution, underpinned by strong cash flow and key project milestones.

Glennon Small Companies Limited reported a half-year loss for the period ending 31 December 2025, driven by significant investment portfolio losses. Despite this, the company declared dividends and extended a key convertible loan.

Bell Financial Group delivered a robust 17.1% rise in net profit after tax to $36 million for 2025, driven by strong growth in its Platforms division and a rebound in market activity. The company declared a fully franked final dividend of 6.5 cents per share, signalling confidence as it prepares to launch a new wealth management platform in 2026.

BKI Investment Company has finalised its on-market share purchases to satisfy its Dividend Reinvestment Plan obligations, setting the DRP price at $1.74 ahead of the 2026 interim dividend payment.

Austral Resources Australia has voluntarily suspended its shares on the ASX to complete a significant placement and secure a strategic investor commitment, with strong demand reported.

Chariot Resources Ltd has voluntarily suspended trading on the ASX as it finalises a significant financing arrangement, with an announcement expected by 20 February 2026.

Mayne Pharma has initiated legal proceedings against Cosette Pharmaceuticals and associated parties, seeking substantial damages following the collapse of their acquisition deal.

BlueScope has received a revised takeover proposal offering $32.35 per share in cash from a consortium of SGH and Steel Dynamics, prompting the Board to reassess the offer amid strategic restructuring plans.

QEM Limited has raised $1.442 million through a well-supported placement to fund a strategic review of its flagship Julia Creek Vanadium and Energy Project and explore new critical minerals opportunities.

Dexus has reported a strong half-year result with a $348.5 million profit turnaround, robust leasing growth, and strategic capital moves including a $950 million equity raise and a 10% on-market buyback.

INOVIQ Limited reported a $3.96 million net loss for H1 2026, driven by increased R&D spend, while securing $10.2 million to accelerate its exosome-based cancer diagnostics and therapeutics pipeline.